Edwards Lifesciences Corporation

EW | NYSE

$93.30

+$1.29 (+1.40%)

Nov 2, 2026, 9:48 AM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
PE Ratio	46.33	10.61	33.01	30.33	53.76	69.11
PEG Ratio	-0.63	0.05	-5.41	14.62	0.65	-3.23
PS Ratio	8.22	8.13	9.23	8.58	15.43	12.95
PB Ratio	4.82	4.43	6.96	7.95	13.84	12.42
P/FCF Ratio	37.34	152.63	73.49	48.44	57.58	87.79
P/OCF Ratio	31.25	81.59	51.64	37.91	46.62	53.87
OCF/S Ratio	26.29	9.97	17.88	22.63	33.10	24.04
Debt / Equity Ratio	0.07	0.07	0.10	0.12	0.12	0.15
Quick Ratio	3.09	3.45	2.62	2.17	2.38	2.56
Current Ratio	3.72	4.18	3.38	3.03	3.08	3.46
Asset Turnover	0.44	0.42	0.54	0.65	0.62	0.61
Interest Coverage	n/a	69.63	81.10	64.98	64.94	58.38
Return on Equity	10.38%	41.75%	21.09%	26.21%	25.76%	18%
Return on Assets	7.84%	31.98%	14.98%	18.35%	17.68%	11.38%
Return on Invested Capital	11.40%	10.74%	15.49%	20.09%	18.97%	18.27%
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	78.13%	79.46%	79.30%	78.31%	76.57%	74.94%
Net Profit Margin	17.69%	76.75%	27.99%	28.28%	28.73%	18.77%
Pretax Profit Margin	20.98%	28.46%	27.39%	32.84%	32.53%	20.90%
Operating Profit Margin	26.97%	25.35%	28.49%	31.63%	30.78%	29.55%
FCF Margin	22%	5.33%	12.56%	17.71%	26.80%	14.75%
EBITDA Margin	23.56%	31.68%	30.64%	36.42%	36.12%	24.49%